JT-1
/ Jantar GmbH
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
March 21, 2023
Proof-of-Concept Interventional Study With a Nasal Spray of JT-1 in Patients With Chronic Rhinitis or Chronic Sinusitis
(clinicaltrials.gov)
- P=N/A | N=3 | Terminated | Sponsor: Jantar GmbH | N=25 ➔ 3 | Trial completion date: Sep 2023 ➔ Mar 2023 | Recruiting ➔ Terminated | Trial primary completion date: Aug 2023 ➔ Mar 2023; regulatory issues
Enrollment change • Trial completion date • Trial primary completion date • Trial termination • Inflammation • Otorhinolaryngology • Respiratory Diseases • Sinusitis
October 03, 2022
Proof-of-Concept Interventional Study With a Nasal Spray of JT-1 in Patients With Chronic Rhinitis or Chronic Sinusitis
(clinicaltrials.gov)
- P=N/A | N=25 | Recruiting | Sponsor: Jantar GmbH | Not yet recruiting ➔ Recruiting
Enrollment open • Inflammation • Otorhinolaryngology • Respiratory Diseases • Sinusitis
August 10, 2022
Proof-of-Concept Interventional Study With a Nasal Spray of JT-1 in Patients With Chronic Rhinitis or Chronic Sinusitis
(clinicaltrials.gov)
- P=N/A | N=25 | Not yet recruiting | Sponsor: Jantar GmbH | Trial completion date: May 2023 ➔ Sep 2023 | Trial primary completion date: May 2023 ➔ Aug 2023
Trial completion date • Trial primary completion date • Inflammation • Otorhinolaryngology • Respiratory Diseases • Sinusitis
April 15, 2022
Proof-of-Concept Interventional Study With a Nasal Spray of JT-1 in Patients With Chronic Rhinitis or Chronic Sinusitis
(clinicaltrials.gov)
- P=N/A | N=25 | Not yet recruiting | Sponsor: Jantar GmbH
New trial • Inflammation • Otorhinolaryngology • Respiratory Diseases • Sinusitis
1 to 4
Of
4
Go to page
1